Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly and | Svizzera | Salute | Prodotti farmaceutici | 652,85 Mrd CHF | 88,7x | 1,27 | 710 CHF | 7,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Roche Holding | Svizzera | Salute | Prodotti farmaceutici | 216,09 Mrd CHF | 19,2x | -5,94 | 271,40 CHF | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,9% Rialzo | Fai l’upgrade a Pro+ | |
Roche Holding Participation | Svizzera | Salute | Prodotti farmaceutici | 203,66 Mrd CHF | 20,4x | -5,94 | 256,30 CHF | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14% Rialzo | Fai l’upgrade a Pro+ | |
Novartis | Svizzera | Salute | Prodotti farmaceutici | 180,77 Mrd CHF | 11,9x | 0,14 | 90,72 CHF | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Novartis | Svizzera | Salute | Prodotti farmaceutici | 180,77 Mrd CHF | 11,9x | 0,14 | 90,38 CHF | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 15,3% Rialzo | Fai l’upgrade a Pro+ | |
Abbott Laboratories | Svizzera | Salute | Attrezzature e forniture medicali | 176,14 Mrd CHF | 35x | 2,98 | 93,50 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Alcon | Svizzera | Salute | Attrezzature e forniture medicali | 37,95 Mrd CHF | 37,2x | 0,24 | 77,16 CHF | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,2% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 37,37 Mrd CHF | 58x | -1,38 | 520 CHF | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,6% Rialzo | Fai l’upgrade a Pro+ | |
Lonza Group | Svizzera | Salute | Ricerca medica e biotecnologica | 37,37 Mrd CHF | 58x | -1,38 | 520 CHF | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,6% Rialzo | Fai l’upgrade a Pro+ | |
Zimmer Biomet Holdings Inc | Svizzera | Salute | Attrezzature e forniture medicali | 19,10 Mrd CHF | 20,7x | 0,16 | 109 CHF | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Straumann Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 18,26 Mrd CHF | 67,3x | -2,27 | 114,45 CHF | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,7% Rialzo | Fai l’upgrade a Pro+ | |
Sonova Holding | Svizzera | Salute | Attrezzature e forniture medicali | 17,81 Mrd CHF | -5,39 | 228,60 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Sonova H Ag | Svizzera | Salute | Attrezzature e forniture medicali | 17,61 Mrd CHF | 31,1x | -5,39 | 296 CHF | -0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,8% Rialzo | Fai l’upgrade a Pro+ | |
Sandoz | Svizzera | Salute | Prodotti farmaceutici | 16,94 Mrd CHF | -2.379,2x | 24,68 | 38,01 CHF | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,3% Rialzo | Fai l’upgrade a Pro+ | |
Ypsomed Holding AG | Svizzera | Salute | Attrezzature e forniture medicali | 5,02 Mrd CHF | 67,4x | 25,09 | 369 CHF | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,1% Rialzo | Fai l’upgrade a Pro+ | |
BACHEM HOLDING AG | Svizzera | Salute | Ricerca medica e biotecnologica | 4,86 Mrd CHF | 42,7x | 3,05 | 64,90 CHF | -2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 22,9% Rialzo | Fai l’upgrade a Pro+ | |
Siegfried Holding Ltd | Svizzera | Salute | Prodotti farmaceutici | 4,62 Mrd CHF | 35,8x | -2,55 | 1.078 CHF | -2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,2% Rialzo | Fai l’upgrade a Pro+ | |
Galenica Sante | Svizzera | Salute | Prodotti farmaceutici | 3,76 Mrd CHF | 21,3x | -0,66 | 75,75 CHF | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,9% Rialzo | Fai l’upgrade a Pro+ | |
Dottikon Es Holding AG | Svizzera | Salute | Prodotti farmaceutici | 3,27 Mrd CHF | 43,6x | 237,50 CHF | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 44,9% Rialzo | Fai l’upgrade a Pro+ | ||
Lepu Medical Tech Beijing DRC | Svizzera | Salute | Attrezzature e forniture medicali | 2,69 Mrd CHF | 34,2x | -0,53 | 15,85 CHF | 12,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Joincare Pharmaceutical DRC | Svizzera | Salute | Prodotti farmaceutici | 2,61 Mrd CHF | 14,7x | 4,92 | 7,04 CHF | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medacta | Svizzera | Salute | Attrezzature e forniture medicali | 2,20 Mrd CHF | 46,2x | 3,28 | 109 CHF | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27,1% Rialzo | Fai l’upgrade a Pro+ | |
BB Biotech | Svizzera | Salute | Ricerca medica e biotecnologica | 2,06 Mrd CHF | 16,4x | 0,12 | 37,45 CHF | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 49,9% Rialzo | Fai l’upgrade a Pro+ | |
SKAN | Svizzera | Salute | Attrezzature e forniture medicali | 1,65 Mrd CHF | 55,9x | 2,89 | 71,50 CHF | -2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,1% Rialzo | Fai l’upgrade a Pro+ | |
Aevis Victoria | Svizzera | Salute | Fornitori e servizi sanitari | 1,11 Mrd CHF | -38,1x | 0,02 | 13,50 CHF | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
COSMO Pharma | Svizzera | Salute | Prodotti farmaceutici | 990,03 Mln CHF | 15,4x | 0,03 | 61,40 CHF | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 42,9% Rialzo | Fai l’upgrade a Pro+ | |
PolyPeptide Group AG | Svizzera | Salute | Prodotti farmaceutici | 931,79 Mln CHF | -35x | -1,65 | 27,75 CHF | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 19,4% Rialzo | Fai l’upgrade a Pro+ | |
Kuros Biosciences | Svizzera | Salute | Ricerca medica e biotecnologica | 738,68 Mln CHF | -64,5x | -2,99 | 19,78 CHF | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medartis | Svizzera | Salute | Attrezzature e forniture medicali | 709,69 Mln CHF | 167,3x | 1,2 | 53 CHF | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Basilea Pharmaceutica AG | Svizzera | Salute | Ricerca medica e biotecnologica | 487,88 Mln CHF | -744,4x | 7,66 | 40,05 CHF | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |